FDA Begins Daily Release of Adverse Event Data to Strengthen Safety Monitoring

The U.S. Food and Drug Administration (FDA) has begun publishing data from its Adverse Event Reporting System (FAERS) on a daily basis, a move officials call a major step toward transparency and real-time public health protection. FAERS serves as the agency’s primary database for tracking adverse events, serious medication errors, and product quality issues related to prescription drugs and biologics, with reports submitted by healthcare providers, patients, and manufacturers.

“Adverse event reporting should be fast, seamless, and transparent,” the FDA said, noting that the new approach eliminates months-long delays in making data available. The daily release is part of the agency’s broader data modernization strategy, aimed at improving reporting frequency and streamlining detection of safety signals.

The public can access updated information through the FAERS Public Dashboard, while healthcare professionals and consumers are encouraged to submit reports via the FDA’s MedWatch system.

25-08-2025